Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dan Scheller"'
Autor:
Tatiana Lebedeva, Jen Poate, Elaine F. Reed, Elizabeth Beduhn, Ana M. Lazaro, Gail Flickinger, Marcelo Fernandez-Vina, Lindsay Carpenter, Dan Scheller
Publikováno v:
Human Immunology. 76:221
Aim Swabs created from BLCLs transformed from peripheral blood mononuclear cells (PBMCs) or expanded from existing BLCLs are used in the Be The Match Registry (BTMR) HLA QC program. The aim of this project was to document mutation as a cause of HLA t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acb88669b37f56a34e949a748d572b2a
https://doi.org/10.1016/j.humimm.2015.01.045
https://doi.org/10.1016/j.humimm.2015.01.045
Autor:
Richard E. Mullins, Mary Frick, J D Pirsch, Leslie M. Shaw, Ashok Jain, Dan Scheller, Mohammed Virji, Diana L. Ersfeld, Raman Venkataramanan, Abraham Shaked, Gordon D. MacFarlane, Kenneth L. Brayman, Laszlo Sarkozi, William E. Fitzsimmons
Publikováno v:
Journal of clinical pharmacology. 41(5)
The relationship between the dose of tacrolimus, trough tacrolimus blood concentration, and selected clinical endpoints (acute rejection, nephrotoxicity, and other toxicities) were examined in a prospective, multicenter clinical trial to validate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775de44d4781c500ca4f8783774d2240
https://pubmed.ncbi.nlm.nih.gov/11361051
https://pubmed.ncbi.nlm.nih.gov/11361051
Autor:
Diana L. Ersfeld, Todd L. Jensen, Dan Scheller, Pui-Yeun Wong, Gordon D. MacFarlane, Anthony Jevans, Masakazu Kobayashi
Publikováno v:
Therapeutic drug monitoring. 18(6)
Tacrolimus (FK506) is a macrolide antibiotic with potent immunosuppressive properties. FK506 is 10- to 100-fold more potent than cyclosporin A in preventing organ rejection and in toxicity. Extreme inter- and intrapatient variability and lack of corr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c30efd336918513bd1fdeb37a46b363
https://pubmed.ncbi.nlm.nih.gov/8946668
https://pubmed.ncbi.nlm.nih.gov/8946668
Autor:
Diana L. Ersfeld, Leslie M. Shaw, Gordon D. MacFarlane, Richard E. Mullins, Dan Scheller, Raman Venkataramanan
Publikováno v:
Therapeutic Drug Monitoring. 21:437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0adb2c68f0395f916ed1d888f5d80662
https://doi.org/10.1097/00007691-199908000-00046
https://doi.org/10.1097/00007691-199908000-00046
Publikováno v:
Therapeutic Drug Monitoring. 19:557
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d32dc96244ee42ce35dfae7a9859736
https://doi.org/10.1097/00007691-199710000-00050
https://doi.org/10.1097/00007691-199710000-00050
Publikováno v:
Therapeutic Drug Monitoring. 19:559
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee5d994a2b4393c02565389e1ed867e6
https://doi.org/10.1097/00007691-199710000-00061
https://doi.org/10.1097/00007691-199710000-00061